Skip to main content
PMC home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1993 Apr;110(2):379–387. doi: 10.1017/s0950268800068321

Antenatal survey for the seroprevalence of HTLV-1 infections in the West Midlands, England.

S Nightingale 1, D Orton 1, D Ratcliffe 1, S Skidmore 1, J Tosswill 1, U Desselberger 1
PMCID: PMC2272267  PMID: 8472781

Abstract

The sera of 3522 women who attended an antenatal clinic in Birmingham, England were tested anonymously for antibodies against HTLV-1. Samples from 5 women (0.14%) were positive, one serum showed indeterminate reactivity. Two of the women (0.06%) were born in the West Indies (of Afro-Caribbean ethnic origin), one (0.03%) in Africa (of African ethnic origin), and three (0.09%) were white Caucasian women born in the UK. Thus, HTLV-1 infection in pregnant women in the UK, though comparatively rare, is not negligible. As transmission of HTLV-1 to the newborn via breast milk has been observed and as seropositive mothers can be advised to refrain from breastfeeding or to treat their milk, the question of routine screening for HTLV-1 infection during antenatal care is discussed.

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ando Y., Nakano S., Saito K., Shimamoto I., Ichijo M., Toyama T., Hinuma Y. Prevention of HTLV-I transmission through the breast milk by a freeze-thawing process. Jpn J Cancer Res. 1986 Oct;77(10):974–977. [PubMed] [Google Scholar]
  2. Banatvala J. E., Chrystie I. L., Palmer S. J., Kenney A. Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic. Lancet. 1990 Apr 7;335(8693):859–860. doi: 10.1016/0140-6736(90)90977-d. [DOI] [PubMed] [Google Scholar]
  3. Blattner W. A., Nomura A., Clark J. W., Ho G. Y., Nakao Y., Gallo R., Robert-Guroff M. Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4895–4898. doi: 10.1073/pnas.83.13.4895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cruickshank J. K., Richardson J. H., Morgan O. S., Porter J., Klenerman P., Knight J., Newell A. L., Rudge P., Dalgleish A. G. Screening for prolonged incubation of HTLV-I infection in British and Jamaican relatives of British patients with tropical spastic paraparesis. BMJ. 1990 Feb 3;300(6720):300–304. doi: 10.1136/bmj.300.6720.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dalgleish A., Richardson J., Matutes E., Cruickshank K., Newell A., Sinclair A., Thorpe R., Brasher M., Weber J., Catovsky D. HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response. AIDS Res Hum Retroviruses. 1988 Dec;4(6):475–485. doi: 10.1089/aid.1988.4.475. [DOI] [PubMed] [Google Scholar]
  6. Elian M., Nightingale S., Dean G. Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies. J Neurol Neurosurg Psychiatry. 1990 Oct;53(10):906–911. doi: 10.1136/jnnp.53.10.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gessain A., Francis H., Sonan T., Giordano C., Akani F., Piquemal M., Caudie C., Malone G., Essex M., de-Thé G. HTLV-I and tropical spastic paraparesis in Africa. Lancet. 1986 Sep 20;2(8508):698–698. doi: 10.1016/s0140-6736(86)90218-7. [DOI] [PubMed] [Google Scholar]
  8. Hartley T. M., Khabbaz R. F., Cannon R. O., Kaplan J. E., Lairmore M. D. Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays. J Clin Microbiol. 1990 Apr;28(4):646–650. doi: 10.1128/jcm.28.4.646-650.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hino S., Doi H., Yoshikuni H., Sugiyama H., Ishimaru T., Yamabe T., Tsuji Y., Miyamoto T. HTLV-I carrier mothers with high-titer antibody are at high risk as a source of infection. Jpn J Cancer Res. 1987 Nov;78(11):1156–1158. [PubMed] [Google Scholar]
  10. Hino S., Sugiyama H., Doi H., Ishimaru T., Yamabe T., Tsuji Y., Miyamoto T. Breaking the cycle of HTLV-I transmission via carrier mothers' milk. Lancet. 1987 Jul 18;2(8551):158–159. doi: 10.1016/s0140-6736(87)92358-0. [DOI] [PubMed] [Google Scholar]
  11. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K. I., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476–6480. doi: 10.1073/pnas.78.10.6476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kajiyama W., Kashiwagi S., Hayashi J., Nomura H., Ikematsu H., Okochi K. Intrafamilial clustering of anti-ATLA-positive persons. Am J Epidemiol. 1986 Nov;124(5):800–806. doi: 10.1093/oxfordjournals.aje.a114456. [DOI] [PubMed] [Google Scholar]
  13. Kajiyama W., Kashiwagi S., Ikematsu H., Hayashi J., Nomura H., Okochi K. Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis. 1986 Nov;154(5):851–857. doi: 10.1093/infdis/154.5.851. [DOI] [PubMed] [Google Scholar]
  14. Kaplan J. E., Osame M., Kubota H., Igata A., Nishitani H., Maeda Y., Khabbaz R. F., Janssen R. S. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr. 1990;3(11):1096–1101. [PubMed] [Google Scholar]
  15. Kazura J. W., Saxinger W. C., Wenger J., Forsyth K., Lederman M. M., Gillespie J. A., Carpenter C. C., Alpers M. A. Epidemiology of human T cell leukemia virus type I infection in East Sepik Province, Papua New Guinea. J Infect Dis. 1987 Jun;155(6):1100–1107. doi: 10.1093/infdis/155.6.1100. [DOI] [PubMed] [Google Scholar]
  16. Lo K. J., Tsai Y. T., Lee S. D., Wu T. C., Wang J. Y., Chen G. H., Yeh C. L., Chiang B. N., Yeh S. H., Goudeau A. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis. 1985 Oct;152(4):817–822. doi: 10.1093/infdis/152.4.817. [DOI] [PubMed] [Google Scholar]
  17. Miyoshi I., Taguchi H., Fujishita M., Niiya K., Kitagawa T., Ohtsuki Y., Akagi T. Asymptomatic type C virus carriers in the family of an adult T-cell leukemia patient. Gan. 1982 Apr;73(2):339–340. [PubMed] [Google Scholar]
  18. Mowbray J., Mawson S., Chawira A., Skidmore S., Boxall E., Desselberger U., Nightingale S. Epidemiology of human T-cell leukaemia/lymphoma virus type 1 (HTLV-1) infections in a subpopulation of Afro-Caribbean origin in England. J Med Virol. 1989 Dec;29(4):289–295. doi: 10.1002/jmv.1890290413. [DOI] [PubMed] [Google Scholar]
  19. Murphy E. L., Hanchard B., Figueroa J. P., Gibbs W. N., Lofters W. S., Campbell M., Goedert J. J., Blattner W. A. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989 Feb 15;43(2):250–253. doi: 10.1002/ijc.2910430214. [DOI] [PubMed] [Google Scholar]
  20. Nerurkar V. R., Miller M. A., Leon-Monzon M. E., Ajdukiewicz A. B., Jenkins C. L., Sanders R. C., Godec M. S., Garruto R. M., Yanagihara R. Failure to isolate human T cell lymphotropic virus type I and to detect variant-specific genomic sequences by polymerase chain reaction in Melanesians with indeterminate western immunoblot. J Gen Virol. 1992 Jul;73(Pt 7):1805–1810. doi: 10.1099/0022-1317-73-7-1805. [DOI] [PubMed] [Google Scholar]
  21. Newton M., Cruickshank K., Miller D., Dalgleish A., Rudge P., Clayden S., Moseley I. Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraparesis. Lancet. 1987 Feb 21;1(8530):415–416. doi: 10.1016/s0140-6736(87)90120-6. [DOI] [PubMed] [Google Scholar]
  22. Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H., Tara M., Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol. 1987 Feb;21(2):117–122. doi: 10.1002/ana.410210203. [DOI] [PubMed] [Google Scholar]
  23. Richardson J. H., Newell A. L., Newman P. K., Mani K. S., Rangan G., Dalgleish A. G. HTLV-I and neurological disease in South India. Lancet. 1989 May 13;1(8646):1079–1079. doi: 10.1016/s0140-6736(89)92475-6. [DOI] [PubMed] [Google Scholar]
  24. Robert-Guroff M., Clark J., Lanier A. P., Beckman G., Melbye M., Ebbesen P., Blattner W. A., Gallo R. C. Prevalence of HTLV-I in Arctic regions. Int J Cancer. 1985 Dec 15;36(6):651–655. doi: 10.1002/ijc.2910360605. [DOI] [PubMed] [Google Scholar]
  25. Saji F., Ohashi K., Tokugawa Y., Kamiura S., Azuma C., Tanizawa O. Perinatal infection of human T-lymphotropic virus type I, the etiologic virus of adult T-cell leukemia/lymphoma. DNA amplification of specific human T-lymphotropic virus type I sequences. Cancer. 1990 Nov 1;66(9):1933–1937. doi: 10.1002/1097-0142(19901101)66:9<1933::aid-cncr2820660914>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  26. Salker R., Tosswill J. H., Barbara J. A., Runganga J., Contreras M., Tedder R. S., Parra-Mejia N., Mortimer P. P. HTLV-I/II antibodies in UK blood donors. Lancet. 1990 Aug 4;336(8710):317–317. doi: 10.1016/0140-6736(90)91856-6. [DOI] [PubMed] [Google Scholar]
  27. Sato H., Okochi K. Transmission of human T-cell leukemia virus (HTLV-I) by blood transfusion: demonstration of proviral DNA in recipients' blood lymphocytes. Int J Cancer. 1986 Mar 15;37(3):395–400. doi: 10.1002/ijc.2910370311. [DOI] [PubMed] [Google Scholar]
  28. Tosswill J. H., Parry J. V., Weber J. N. Application of screening and confirmatory assays for anti-HTLV-I/II in U.K. populations. J Med Virol. 1992 Mar;36(3):167–171. doi: 10.1002/jmv.1890360304. [DOI] [PubMed] [Google Scholar]
  29. Tsuji Y., Doi H., Yamabe T., Ishimaru T., Miyamoto T., Hino S. Prevention of mother-to-child transmission of human T-lymphotropic virus type-I. Pediatrics. 1990 Jul;86(1):11–17. [PubMed] [Google Scholar]
  30. Vernant J. C., Maurs L., Gessain A., Barin F., Gout O., Delaporte J. M., Sanhadji K., Buisson G., de-Thé G. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases. Ann Neurol. 1987 Feb;21(2):123–130. doi: 10.1002/ana.410210204. [DOI] [PubMed] [Google Scholar]
  31. Weber J. N., Banatvala N., Clayden S., McAdam K. P., Palmer S., Moulsdale H., Tosswill J., Dilger P., Thorpe R., Amann S. HTLV-1 infection in Papua New Guinea: evidence for serologic false positivity. J Infect Dis. 1989 Jun;159(6):1025–1028. doi: 10.1093/infdis/159.6.1025. [DOI] [PubMed] [Google Scholar]
  32. Weber J. HTLV-I infection in Britain. BMJ. 1990 Jul 14;301(6743):71–72. doi: 10.1136/bmj.301.6743.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wheeley S. M., Boxall E. H., Tarlow M. J., Gatrad A. R., Anderson J., Bissenden J., Chin K. C., Mayne A. Hepatitis B vaccine in the prevention of perinatally transmitted hepatitis B virus infection: final report on a West Midlands pilot study. J Med Virol. 1990 Feb;30(2):113–116. doi: 10.1002/jmv.1890300207. [DOI] [PubMed] [Google Scholar]
  34. Yamanouchi K., Kinoshita K., Moriuchi R., Katamine S., Amagasaki T., Ikeda S., Ichimaru M., Miyamoto T., Hino S. Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission. Jpn J Cancer Res. 1985 Jun;76(6):481–487. [PubMed] [Google Scholar]
  35. Yamato K., Taguchi H., Yoshimoto S., Fujishita M., Yamashita M., Ohtsuki Y., Hoshino H., Miyoshi I. Inactivation of lymphocyte-transforming activity of human T-cell leukemia virus type I by heat. Jpn J Cancer Res. 1986 Jan;77(1):13–15. [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES